Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Levodopa on Depression in Patients with Parkinson Disease
IRCT2014092119243N1Phase 2Completed
- Sponsor
- Shiraz University of Medical Sciences
- Start
- Nov 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of levodopa in Parkinson's disease (PD) and major depressive disorder (MDD), sponsored by Shiraz University of Medical Sciences. Primary endpoint: Change in depression symptoms. Started Nov 2015; status: completed.
02
Drugs
levodopa
03
Conditions
Parkinson's disease (PD)major depressive disorder (MDD)
Beyond the preview
Go deeper on IRCT2014092119243N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2014092119243N1.